No pain data yet from Vertex, and sky high deal expectations at JPM 2024

Today’s Readout newsletter: Sky high deal expectations going into JPM 2024, no pain data yet from Vertex, is JPM good for the XBI and other biotech news updates.
Click here to view original post

Advertisement — Advertise with Biotech Networks